Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today granted de novo clearance that permits marketing of Hologic's Aptima assay for Mycoplasma genitalium sexually-transmitted infection in men and women.

The FDA said that this is the first test it has authorized to test for M. genitalium, a slow-growing bacterium that is difficult to detect with traditional laboratory methods and is associated with inflammation of the urethra in men and inflammation of the cervix and infection of the reproductive organs in women.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.

In a column at the Dallas Morning News, the Stanley Medical Research Institute's E. Fuller Torrey says the Human Genome Project hasn't delivered on promised results.

Researchers explore a possible genetic cause for some cases of sudden infant death syndrome, KOMO News reports.